BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2020;11:571416. [PMID: 33510644 DOI: 10.3389/fphys.2020.571416] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 40.0] [Reference Citation Analysis]
Number Citing Articles
1 Matusali G, Sberna G, Meschi S, Gramigna G, Colavita F, Lapa D, Francalancia M, Bettini A, Capobianchi MR, Puro V, Castilletti C, Vaia F, Bordi L. Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up. Viruses 2022;14:312. [DOI: 10.3390/v14020312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Li Y, Wang C, Peng M. Aging Immune System and Its Correlation With Liability to Severe Lung Complications. Front Public Health 2021;9:735151. [PMID: 34888279 DOI: 10.3389/fpubh.2021.735151] [Reference Citation Analysis]
3 Israel A, Merzon E, Schäffer AA, Shenhar Y, Green I, Golan-Cohen A, Ruppin E, Magen E, Vinker S. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. medRxiv 2021:2021. [PMID: 34401882 DOI: 10.1101/2021.08.03.21261496] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 27.0] [Reference Citation Analysis]
4 Vilibic-Cavlek T, Stevanovic V, Ilic M, Barbic L, Capak K, Tabain I, Krleza JL, Ferenc T, Hruskar Z, Topic RZ, Kaliterna V, Antolovic-Pozgain A, Kucinar J, Koscak I, Mayer D, Sviben M, Antolasic L, Milasincic L, Bucic L, Ferencak I, Kaic B. SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia. Pathogens 2021;10:774. [PMID: 34203060 DOI: 10.3390/pathogens10060774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open 2021;11:e054208. [PMID: 34916326 DOI: 10.1136/bmjopen-2021-054208] [Reference Citation Analysis]
6 Alaeddini M, Etemad-moghadam S. SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.05.017] [Reference Citation Analysis]
7 Masiá M, Fernández-González M, Telenti G, Agulló V, García JA, Padilla S, García-Abellán J, Galiana A, Gonzalo-Jiménez N, Gutiérrez F. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study. J Autoimmun 2021;123:102703. [PMID: 34303083 DOI: 10.1016/j.jaut.2021.102703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Taylor SC, Hurst B, Martiszus I, Hausman MS, Sarwat S, Schapiro JM, Rowell S, Lituev A. Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination. Vaccine 2021;39:5688-98. [PMID: 34426026 DOI: 10.1016/j.vaccine.2021.07.098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Parant F, Bouloy J, Haesebaert J, Bendim'red L, Goldet K, Vanhems P, Henaff L, Gilbert T, Cuerq C, Blond E, Bost M, Bonnefoy M. Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation. Nutrients 2022;14:1641. [PMID: 35458203 DOI: 10.3390/nu14081641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mahmood ZS, Fadhil HY, Abdul Hussein TA, Ad'hiah AH. Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients. Meta Gene 2022;:101014. [PMID: 35036327 DOI: 10.1016/j.mgene.2022.101014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Aoki Y, Mehmet SC. The COVID-19 pandemic appears to have increased longevity in Japanese centenarians. Age Ageing 2021;50:1052-3. [PMID: 33909007 DOI: 10.1093/ageing/afab077] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ukaj N, Scheiner S, Hellmich C. Toward “hereditary epidemiology”: A temporal Boltzmann approach to COVID-19 fatality trends. Applied Physics Reviews 2021;8:041417. [DOI: 10.1063/5.0062867] [Reference Citation Analysis]
14 Speranza E, Purushotham JN, Port JR, Schwarz B, Flagg M, Williamson BN, Feldmann F, Singh M, Pérez-Pérez L, Sturdevant GL, Roberts LM, Carmody A, Schulz JE, van Doremalen N, Okumura A, Lovaglio J, Hanley PW, Shaia C, Germain RN, Best SM, Munster VJ, Bosio CM, de Wit E. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques. Life Sci Alliance 2022;5:e202101314. [PMID: 35039442 DOI: 10.26508/lsa.202101314] [Reference Citation Analysis]
15 Li JY, Zhou ZJ, Wang Q, He QN, Zhao MY, Qiu Y, Ge XY. Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. Front Microbiol 2021;12:770656. [PMID: 34777324 DOI: 10.3389/fmicb.2021.770656] [Reference Citation Analysis]
16 Putri DU, Wang CH, Tseng PC, Lee WS, Chen FL, Kuo HP, Lee CH, Lin CF. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods. Viruses 2021;13:514. [PMID: 33808906 DOI: 10.3390/v13030514] [Reference Citation Analysis]
17 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
18 Saldaña J, Scoglio C. Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2. Sci Rep 2022;12:2640. [PMID: 35173229 DOI: 10.1038/s41598-022-06477-0] [Reference Citation Analysis]
19 Traoré A, Guindo MA, Konaté D, Traoré B, Diakité SA, Kanté S, Dembélé A, Cissé A, Incandela NC, Kodio M, Coulibaly YI, Faye O, Kajava AV, Pratesi F, Migliorini P, Papini AM, Pacini L, Rovero P, Errante F, Diakité M, Arevalo-Herrera M, Herrera S, Corradin G, Balam S. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas. Front Immunol 2022;13:856033. [PMID: 35585976 DOI: 10.3389/fimmu.2022.856033] [Reference Citation Analysis]
20 Zinatizadeh MR, Zarandi PK, Zinatizadeh M, Yousefi MH, Amani J, Rezaei N. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines. Biomed Pharmacother 2021;146:112527. [PMID: 34906769 DOI: 10.1016/j.biopha.2021.112527] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
21 Azzini E, Peluso I, Intorre F, Barnaba L, Venneria E, Foddai MS, Ciarapica D, Maiani F, Raguzzini A, Polito A. Total and Plant Protein Consumption: The Role of Inflammation and Risk of Non-Communicable Disease. IJMS 2022;23:8008. [DOI: 10.3390/ijms23148008] [Reference Citation Analysis]
22 Azad Allarakia BM, Gattan HS, Abdeen RH, Al-ahmadi BM, Shater AF, Bazaid MB, Althomali OW, Bazaid AS, Ledda C. Predicting Intensive Care Unit Admission for COVID-19 Patients from Laboratory Results. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/4623901] [Reference Citation Analysis]
23 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
24 Ryu G, Shin HW. SARS-CoV-2 Infection of Airway Epithelial Cells. Immune Netw 2021;21:e3. [PMID: 33728096 DOI: 10.4110/in.2021.21.e3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
25 Gediz Erturk A, Sahin A, Bati Ay E, Pelit E, Bagdatli E, Kulu I, Gul M, Mesci S, Eryilmaz S, Oba Ilter S, Yildirim T. A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 2021;26:3526. [PMID: 34207756 DOI: 10.3390/molecules26123526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Alhaddad F, Abdulkareem A, Alsharrah D, Alkandari A, Bin-Hasan S, Al-Ahmad M, Al Hashemi H, Alghounaim M. Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait. BMJ Open 2022;12:e056371. [PMID: 35768102 DOI: 10.1136/bmjopen-2021-056371] [Reference Citation Analysis]
27 Gomaa AA, Mohamed HS, Abd-Ellatief RB, Gomaa MA. Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology 2021;29:1033-48. [PMID: 34224069 DOI: 10.1007/s10787-021-00841-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Williams GH, Llewelyn A, Brandao R, Chowdhary K, Hardisty KM, Loddo M. SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom. EClinicalMedicine 2021;38:101021. [PMID: 34278277 DOI: 10.1016/j.eclinm.2021.101021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Avendaño-Ortiz J, Lozano-Rodríguez R, Martín-Quirós A, Terrón V, Maroun-Eid C, Montalbán-Hernández K, Valentín-Quiroga J, García-Garrido MÁ, Del Val EM, Del Balzo-Castillo Á, Peinado M, Gómez L, Herrero-Benito C, Rubio C, Casalvilla-Dueñas JC, Gómez-Campelo P, Pascual-Iglesias A, Del Fresno C, Aguirre LA, López-Collazo E. The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission. Clin Transl Med 2021;11:e573. [PMID: 34709745 DOI: 10.1002/ctm2.573] [Reference Citation Analysis]
30 Getachew B, Tizabi Y. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity. J Med Virol 2021;93:5285-94. [PMID: 33990955 DOI: 10.1002/jmv.27075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Reference Citation Analysis]
32 Taborska P, Strizova Z, Stakheev D, Sojka L, Bartunkova J, Smrz D. CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. Front Immunol 2021;12:629102. [PMID: 34012431 DOI: 10.3389/fimmu.2021.629102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Saunders HA, Schwartz JM. COVID-19 vaccination strategies depend on the underlying network of social interactions. Sci Rep 2021;11:24051. [PMID: 34912001 DOI: 10.1038/s41598-021-03167-1] [Reference Citation Analysis]
35 Damayanthi HDWT, Prabani KIP, Weerasekara I. Factors Associated for Mortality of Older People With COVID 19: A Systematic Review and Meta-analysis. Gerontol Geriatr Med 2021;7:23337214211057392. [PMID: 34888405 DOI: 10.1177/23337214211057392] [Reference Citation Analysis]
36 Israel A, Merzon E, Schäffer AA, Shenhar Y, Green I, Golan-Cohen A, Ruppin E, Magen E, Vinker S. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ 2021;375:e067873. [PMID: 34819275 DOI: 10.1136/bmj-2021-067873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
37 Fukushi I, Nakamura M, Kuwana SI. Effects of wearing facemasks on the sensation of exertional dyspnea and exercise capacity in healthy subjects. PLoS One 2021;16:e0258104. [PMID: 34591935 DOI: 10.1371/journal.pone.0258104] [Reference Citation Analysis]
38 Dawood SS, Eweida RS, Rashwan ZI, Elmoniem MMA, Elsakhy NM. Older Adults' Perceived Risk Regarding COVID-19 and Intention to Vaccinate: Role of Health-Related Literacy. Res Gerontol Nurs 2022;15:57-67. [PMID: 35312437 DOI: 10.3928/19404921-20220218-02] [Reference Citation Analysis]
39 Mileto D, Fenizia C, Cutrera M, Gagliardi G, Gigantiello A, De Silvestri A, Rizzo A, Mancon A, Bianchi M, De Poli F, Cuomo M, Burgo I, Longo M, Rimoldi SG, Pagani C, Grosso S, Micheli V, Rizzardini G, Biasin M, Gismondo MR, Lombardi A. SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response. Emerg Microbes Infect 2021;:1-29. [PMID: 34749573 DOI: 10.1080/22221751.2021.2004866] [Reference Citation Analysis]
40 Schiffers C, Reynaert NL, Wouters EFM, van der Vliet A. Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies. Antioxidants (Basel) 2021;10:1799. [PMID: 34829671 DOI: 10.3390/antiox10111799] [Reference Citation Analysis]
41 Tsilingiris D, Nasiri-ansari N, Spyrou N, Magkos F, Dalamaga M. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges. Cancers 2022;14:2494. [DOI: 10.3390/cancers14102494] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273. Clin Microbiol Infect 2021:S1198-743X(21)00496-1. [PMID: 34547457 DOI: 10.1016/j.cmi.2021.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
43 Hou Y, Su W, Chao Y. COVID-19 Illness Severity in the Elderly in Relation to Vegetarian and Non-vegetarian Diets: A Single-Center Experience. Front Nutr 2022;9:837458. [DOI: 10.3389/fnut.2022.837458] [Reference Citation Analysis]
44 Muñoz-Fontela C, Widerspick L, Albrecht RA, Beer M, Carroll MW, de Wit E, Diamond MS, Dowling WE, Funnell SGP, García-Sastre A, Gerhards NM, de Jong R, Munster VJ, Neyts J, Perlman S, Reed DS, Richt JA, Riveros-Balta X, Roy CJ, Salguero FJ, Schotsaert M, Schwartz LM, Seder RA, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Advances and gaps in SARS-CoV-2 infection models. PLoS Pathog 2022;18:e1010161. [PMID: 35025969 DOI: 10.1371/journal.ppat.1010161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
45 Pence BD. Aging and monocyte immunometabolism in COVID-19. Aging (Albany NY) 2021;13:9154-5. [PMID: 33795524 DOI: 10.18632/aging.202918] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Babamale AO, Abdulkareem AO, Yinka OJ, Folasade K, Olatundun BO, Ayodipo OF, Uddin MM, Ugbomoiko US. High parasitaemia correlates with malaria episodes and the socioeconomic impact of recurrent malaria infection in high-transmission zone of Nigeria. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00846-5] [Reference Citation Analysis]
47 Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Kuramoto AC, Almeida RR, Ferreira MA, Scagion GP, Candido ÉD, Leal FB, Oliveira DBL, Durigon EL, Silva RCV Jr, Rosa DS, Boscardin SB, Coelho V, Kalil J, Santos KS, Cunha-Neto E. Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old. Front Immunol 2022;13:812126. [PMID: 35300337 DOI: 10.3389/fimmu.2022.812126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Mukherjee S, Mondal S, Bagchi B. Stochastic formulation of multiwave pandemic: decomposition of growth into inherent susceptibility and external infectivity distributions. J Chem Sci (Bangalore) 2021;133:118. [PMID: 34812227 DOI: 10.1007/s12039-021-01981-8] [Reference Citation Analysis]
49 Oba S, Altınay M, Salkaya A, Türk HŞ. Evaluation of the effect of clinical characteristics and intensive care treatment methods on the mortality of covid-19 patients aged 80 years and older. BMC Anesthesiol 2021;21:291. [PMID: 34809556 DOI: 10.1186/s12871-021-01511-6] [Reference Citation Analysis]
50 Kim S, Hwang J. Examining Risk Factors for Mental Health During the COVID-19 Pandemic—Focusing on Older Adults in South Korea. Int J Public Health 2022;67:1604487. [DOI: 10.3389/ijph.2022.1604487] [Reference Citation Analysis]
51 Coutant F, Pin JJ, Morfin-Sherpa F, Ferry T, Paul S, Pozzetto B, Normand M, Miossec P. Impact of Host Immune Status on Discordant Anti-SARS-CoV-2 Circulating B Cell Frequencies and Antibody Levels. Int J Mol Sci 2021;22:11095. [PMID: 34681752 DOI: 10.3390/ijms222011095] [Reference Citation Analysis]
52 Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells 2021;10:3367. [PMID: 34943875 DOI: 10.3390/cells10123367] [Reference Citation Analysis]
53 Farheen S, Agrawal S, Zubair S, Agrawal A, Jamal F, Altaf I, Kashif Anwar A, Umair SM, Owais M. Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients. Front Aging 2021;2:748591. [DOI: 10.3389/fragi.2021.748591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Nagaraja S, Jain D, Kesavardhana S. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats. J Leukoc Biol 2021. [PMID: 34057760 DOI: 10.1002/JLB.4COVHR0221-093RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Subramaniyan B, Larabee JL, Bodas M, Moore AR, Burgett AWG, Myers DA, Georgescu C, Wren JD, Papin JF, Walters MS. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals. Viruses 2021;13:1603. [PMID: 34452468 DOI: 10.3390/v13081603] [Reference Citation Analysis]
56 Cham LB, Pahus MH, Grønhøj K, Olesen R, Ngo H, Monrad I, Kjolby M, Tolstrup M, Gunst JD, Søgaard OS. Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 Patients. J Clin Med 2021;10:4798. [PMID: 34682920 DOI: 10.3390/jcm10204798] [Reference Citation Analysis]
57 Shenoy S. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection. Inflamm Res 2021. [PMID: 34738147 DOI: 10.1007/s00011-021-01510-w] [Reference Citation Analysis]
58 Zivancevic-simonovic S, Jovanovic D, Cupurdija V, Milosevic-djordjevic O, Stanojevic M, Marinkovic M, Igrutinovic N, Stanojevic I, Vojvodic D, Mihaljevic O. Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation. Inflamm Res . [DOI: 10.1007/s00011-022-01543-9] [Reference Citation Analysis]
59 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Cheng X, Wan H, Yuan H, Zhou L, Xiao C, Mao S, Li Z, Hu F, Yang C, Zhu W, Zhou J, Zhang T. Symptom Clustering Patterns and Population Characteristics of COVID-19 Based on Text Clustering Method. Front Public Health 2022;10:795734. [DOI: 10.3389/fpubh.2022.795734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Chen C, Feng T, Gu X. Role of latent factors and public policies in travel decisions under COVID-19 pandemic: Findings of a hybrid choice model. Sustain Cities Soc 2022;78:103601. [PMID: 35004132 DOI: 10.1016/j.scs.2021.103601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
62 Spicer KB, Glick C, Cavanaugh AM, Thoroughman D. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020. Int J Infect Dis 2021;114:21-8. [PMID: 34649001 DOI: 10.1016/j.ijid.2021.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
63 Şener B, Kirbaş E, Sancak B, Gözalan A, Evren E, Karahan ZC, Zeytinoğlu A, Dinç B, Alp A, Dizman GT, Metan G, Birengel S, Gülten E, Taşbakan M, Ayhan M. PERFORMANCE EVALUATION OF SIX DIFFERENT SARS-CoV-2 ANTIBODY IMMUNOASSAYS: DISEASE SEVERITY AND SERUM SAMPLING TIME AFFECT THE SENSITIVITY. Jpn J Infect Dis 2022. [PMID: 35354702 DOI: 10.7883/yoken.JJID.2021.636] [Reference Citation Analysis]
64 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Reference Citation Analysis]
65 Neil JA, Griffith M, Godfrey DI, Purcell DFJ, Deliyannis G, Jackson D, Rockman S, Subbarao K, Nolan T. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines. Expert Rev Vaccines 2022;:1-16. [PMID: 35652289 DOI: 10.1080/14760584.2022.2071264] [Reference Citation Analysis]
66 Minnai F, De Bellis G, Dragani TA, Colombo F. COVID-19 mortality in Italy varies by patient age, sex and pandemic wave. Sci Rep 2022;12:4604. [PMID: 35301379 DOI: 10.1038/s41598-022-08573-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
67 Gomes D, Beyerlein A, Katz K, Hoelscher G, Nennstiel U, Liebl B, Überla K, von Kries R. Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany. PLoS One 2021;16:e0259370. [PMID: 34739520 DOI: 10.1371/journal.pone.0259370] [Reference Citation Analysis]
68 Ahmed AA, Ad'hiah AH. Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19). Cytokine 2021;148:155702. [PMID: 34534925 DOI: 10.1016/j.cyto.2021.155702] [Reference Citation Analysis]
69 Ruan W, Nguyen H, Wyatt A, Ihekweazu F, Vartabedian BS, Karam L, Walsh S, Kellermayer R. High Seroconversion Rate Against Severe Acute Respiratory Syndrome Coronavirus 2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients. J Pediatr Gastroenterol Nutr 2021;73:363-6. [PMID: 34173793 DOI: 10.1097/MPG.0000000000003211] [Reference Citation Analysis]
70 Zulu MZ, Sureshchandra S, Pinski AN, Doratt B, Shen W, Messaoudi I. Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients. Front Immunol 2021;12:760288. [PMID: 34707619 DOI: 10.3389/fimmu.2021.760288] [Reference Citation Analysis]
71 Chen XQ, Xing Z, Chen QD, Salvi RJ, Zhang X, Tycko B, Mobley WC, Yu YE. Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome. Front Aging Neurosci 2021;13:700280. [PMID: 34276349 DOI: 10.3389/fnagi.2021.700280] [Reference Citation Analysis]
72 Bariola JR, McCreary EK, Wadas RJ, Kip KE, Marroquin OC, Minnier T, Koscumb S, Collins K, Schmidhofer M, Shovel JA, Wisniewski MK, Sullivan C, Yealy DM, Nace DA, Huang DT, Haidar G, Khadem T, Linstrum K, Seymour CW, Montgomery SK, Angus DC, Snyder GM. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis 2021;8:ofab254. [PMID: 34250192 DOI: 10.1093/ofid/ofab254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Mustafa S, Alomair LA, Hussein M. In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19. Processes 2022;10:1397. [DOI: 10.3390/pr10071397] [Reference Citation Analysis]
74 Dessie AM, Feleke SF, Anley DT, Anteneh RM, Demissie ZA, Zhang J. Assessment of Factors Affecting Time to Recovery from COVID-19: A Retrospective Study in Ethiopia. Advances in Public Health 2022;2022:1-7. [DOI: 10.1155/2022/7182517] [Reference Citation Analysis]
75 Cui X, Wang S, Jiang N, Li Z, Li X, Jin M, Yang B, Jia N, Hu G, Liu Y, He Y, Liu Y, Zhao S, Yu Q. Establishment of prediction models for COVID-19 patients in different age groups based on random Forest algorithm. QJM 2021:hcab268. [PMID: 34668535 DOI: 10.1093/qjmed/hcab268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Bert F, Scaioli G, Vola L, Accortanzo D, Lo Moro G, Siliquini R. Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries. Int J Environ Res Public Health 2022;19:7233. [PMID: 35742479 DOI: 10.3390/ijerph19127233] [Reference Citation Analysis]
77 Yimenicioglu S, Ekici A. COVID-19, Symptoms with Pre-Existing and Not Pre-Existing Neurological Disorders in Pediatrics. J Pediatr Infect Dis. [DOI: 10.1055/s-0042-1748921] [Reference Citation Analysis]
78 Szczepanek J, Skorupa M, Goroncy A, Jarkiewicz-Tretyn J, Wypych A, Sandomierz D, Jarkiewicz-Tretyn A, Dejewska J, Ciechanowska K, Pałgan K, Rajewski P, Tretyn A. Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines. Vaccines (Basel) 2022;10:99. [PMID: 35062760 DOI: 10.3390/vaccines10010099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
79 Hernandez-Garcia E, Chrysikou E, Kalea AZ. The Interplay between Housing Environmental Attributes and Design Exposures and Psychoneuroimmunology Profile-An Exploratory Review and Analysis Paper in the Cancer Survivors' Mental Health Morbidity Context. Int J Environ Res Public Health 2021;18:10891. [PMID: 34682637 DOI: 10.3390/ijerph182010891] [Reference Citation Analysis]
80 Mohiuddin M, Kasahara K. Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence. Respir Med 2021;186:106517. [PMID: 34186259 DOI: 10.1016/j.rmed.2021.106517] [Reference Citation Analysis]
81 Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the Ageing Immune System. Nat Aging 2021;1:769-82. [PMID: 34746804 DOI: 10.1038/s43587-021-00114-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
82 Gaspar T, Paiva T, Matos MG. Ecological Model Explaining the Psychosocial Adaptation to COVID-19. IJERPH 2022;19:5159. [DOI: 10.3390/ijerph19095159] [Reference Citation Analysis]
83 Hamed ME, Naeem A, Alkadi H, Alamri AA, AlYami AS, AlJuryyan A, Alturaiki W, Enani M, Al-Shouli ST, Assiri AM, Alosaimi B. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality. J Clin Immunol 2021. [PMID: 34232441 DOI: 10.1007/s10875-021-01061-z] [Reference Citation Analysis]
84 Kwiecińska-Piróg J, Przekwas J, Kraszewska Z, Sękowska A, Brodzka S, Wiktorczyk-Kapischke N, Grudlewska-Buda K, Wałecka-Zacharska E, Zacharski M, Mańkowska-Cyl A, Gospodarek-Komkowska E, Skowron K. The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland. Vaccines (Basel) 2021;9:1402. [PMID: 34960148 DOI: 10.3390/vaccines9121402] [Reference Citation Analysis]
85 Ranzani OT, Hitchings MDT, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, Villela EFM, Torres MSS, de Oliveira SB, Schulz W, Almiron M, Said R, de Oliveira RD, Vieira da Silva P, de Araújo WN, Gorinchteyn JC, Andrews JR, Cummings DAT, Ko AI, Croda J. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ 2021;374:n2015. [PMID: 34417194 DOI: 10.1136/bmj.n2015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
86 Sepand MR, Bigdelou B, Ho JQ, Sharaf M, Lannigan AJ, Sullivan IM, da Silva AP, Barrett LO, Mcgoldrick S, Lnu Y, Lynch SE, Boisclair JM, Barnard-pratt DD, Zanganeh S. Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines. Antibodies 2022;11:35. [DOI: 10.3390/antib11020035] [Reference Citation Analysis]
87 Kumar PK, Banerjee M, Bajpayee A, Mandal S, Mitra P, Sharma P, Misra S, Bhardwaj P. SARS-CoV-2 IgG Antibody and its Clinical Correlates in Convalescent Plasma Donors: An Indian Experience. Indian J Clin Biochem 2021;:1-9. [PMID: 34812224 DOI: 10.1007/s12291-021-01012-w] [Reference Citation Analysis]
88 Mancilla-Galindo J, Kammar-García A, Martínez-Esteban A, Meza-Comparán HD, Mancilla-Ramírez J, Galindo-Sevilla N. COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms. Epidemiol Infect 2021;149:e230. [PMID: 34674789 DOI: 10.1017/S095026882100234X] [Reference Citation Analysis]
89 Toppi E, De Molfetta V, Zarletti G, Tiberi M, Bossù P, Scapigliati G. The Anti-SARS-CoV-2 Antibody Response in a Centenarian Woman: A Case of Long-Term Memory? Viruses 2021;13:1704. [PMID: 34578286 DOI: 10.3390/v13091704] [Reference Citation Analysis]
90 Gómez-Aguado I, Rodríguez-Castejón J, Beraza-Millor M, Vicente-Pascual M, Rodríguez-Gascón A, Garelli S, Battaglia L, Del Pozo-Rodríguez A, Solinís MÁ. mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics 2021;13:1472. [PMID: 34575548 DOI: 10.3390/pharmaceutics13091472] [Reference Citation Analysis]
91 Xia W, Li M, Wang Y, Kazis LE, Berlo K, Melikechi N, Chiklis GR. Longitudinal analysis of antibody decay in convalescent COVID-19 patients. Sci Rep 2021;11:16796. [PMID: 34408200 DOI: 10.1038/s41598-021-96171-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
92 Bellanti F, Lo Buglio A, Vendemiale G. Redox Homeostasis and Immune Alterations in Coronavirus Disease-19. Biology (Basel) 2022;11:159. [PMID: 35205026 DOI: 10.3390/biology11020159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Lengelé L, Locquet M, Moutschen M, Beaudart C, Kaux JF, Gillain S, Reginster JY, Bruyère O. Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults. Aging Clin Exp Res 2022;34:223-34. [PMID: 34689315 DOI: 10.1007/s40520-021-01991-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Seon JY, Jeon WH, Bae SC, Eun BL, Choung JT, Oh IH. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea. J Korean Med Sci 2021;36:e148. [PMID: 34032033 DOI: 10.3346/jkms.2021.36.e148] [Reference Citation Analysis]
95 Guzmán-Martínez O, Guardado K, de Guevara EL, Navarro S, Hernández C, Zenteno-Cuevas R, Montero H. IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population. Vaccines (Basel) 2021;9:999. [PMID: 34579236 DOI: 10.3390/vaccines9090999] [Reference Citation Analysis]
96 Thuku P. The Relationship Between Community Adherence to COVID-19 Containment Measures and the Wellbeing of Older Adults in Rural Kenya. Gerontology and Geriatric Medicine 2022;8:233372142211059. [DOI: 10.1177/23337214221105981] [Reference Citation Analysis]
97 Pinski AN, Steffen TL, Zulu MZ, George SL, Dickson A, Tifrea D, Maroney KJ, Tedeschi N, Zhang Y, Scheuermann RH, Pinto AK, Brien JD, Messaoudi I. Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation. J Leukoc Biol 2021. [PMID: 34730254 DOI: 10.1002/JLB.4COVA0121-084RR] [Reference Citation Analysis]
98 Lo Tartaro D, Neroni A, Paolini A, Borella R, Mattioli M, Fidanza L, Quong A, Petes C, Awong G, Douglas S, Lin D, Nieto J, Gozzi L, Franceschini E, Busani S, Nasi M, Mattioli AV, Trenti T, Meschiari M, Guaraldi G, Girardis M, Mussini C, Gibellini L, Cossarizza A, De Biasi S. Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia. Commun Biol 2022;5:590. [PMID: 35710943 DOI: 10.1038/s42003-022-03537-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Kim Y, Cheon S, Jeong H, Park U, Ha NY, Lee J, Sohn KM, Kim YS, Cho NH. Differential Association of Viral Dynamics With Disease Severity Depending on Patients' Age Group in COVID-19. Front Microbiol 2021;12:712260. [PMID: 34367117 DOI: 10.3389/fmicb.2021.712260] [Reference Citation Analysis]
100 Chavda VP, Chhabria MT, Apostolopoulos V. Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes. Biologics 2022;2:165-70. [DOI: 10.3390/biologics2030013] [Reference Citation Analysis]
101 Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell 2022;21:e13646. [PMID: 35645319 DOI: 10.1111/acel.13646] [Reference Citation Analysis]
102 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Reference Citation Analysis]
103 Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M, Shekarian T, Liang O, Hutter G, Esfandiarpour R, Zanganeh S. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front Immunol 2022;13:890517. [PMID: 35711466 DOI: 10.3389/fimmu.2022.890517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
104 Máčová L, Bičíková M, Hampl R. Endocrine risk factors for COVID-19 in context of aging. Physiol Res 2021;70:S153-9. [PMID: 34913349 DOI: 10.33549/physiolres.934723] [Reference Citation Analysis]
105 Samanovic MI, Cornelius AR, Gray-Gaillard SL, Allen JR, Karmacharya T, Wilson JP, Hyman SW, Tuen M, Koralov SB, Mulligan MJ, Herati RS. Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals. Sci Transl Med 2022;14:eabi8961. [PMID: 34874183 DOI: 10.1126/scitranslmed.abi8961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
106 Müller L, Di Benedetto S. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19. Int J Mol Sci 2021;22:12539. [PMID: 34830421 DOI: 10.3390/ijms222212539] [Reference Citation Analysis]
107 Perfilyeva YV, Ostapchuk YO, Tleulieva R, Kali A, Abdolla N, Krasnoshtanov VK, Perfilyeva AV, Belyaev NN. Myeloid-derived suppressor cells in COVID-19: A review. Clin Immunol 2022;:109024. [PMID: 35489643 DOI: 10.1016/j.clim.2022.109024] [Reference Citation Analysis]
108 Pallett SJ, Jones R, Abdulaal A, Pallett MA, Rayment M, Patel A, Denny SJ, Mughal N, Khan M, Rosadas de Oliveira C, Pantelidis P, Randell P, Toumazou C, O'Shea MK, Tedder R, McClure MO, Davies GW, Moore LS. Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020. Euro Surveill 2022;27. [PMID: 35086612 DOI: 10.2807/1560-7917.ES.2022.27.4.2002076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Battisti S, Napoli N, Pedone C, Lombardi M, Leanza G, Tramontana F, Faraj M, Agnoletti V, Verna M, Viola L, Giampalma E, Strollo R. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine 2021;74:461-9. [PMID: 34529239 DOI: 10.1007/s12020-021-02872-1] [Reference Citation Analysis]
110 Lukaszuk K, Kiewisz J, Rozanska K, Dabrowska M, Podolak A, Jakiel G, Woclawek-Potocka I, Lukaszuk A, Rabalski L. Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination. Vaccines (Basel) 2021;9:840. [PMID: 34451965 DOI: 10.3390/vaccines9080840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
111 Dzobo K. Coronavirus Disease 19 and Future Ecological Crises: Hopes from Epigenomics and Unraveling Genome Regulation in Humans and Infectious Agents. OMICS 2021;25:269-78. [PMID: 33904782 DOI: 10.1089/omi.2021.0024] [Reference Citation Analysis]
112 Liao MT, Wu CC, Wu SV, Lee MC, Hu WC, Tsai KW, Yang CH, Lu CL, Chiu SK, Lu KC. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants (Basel) 2021;10:1440. [PMID: 34573071 DOI: 10.3390/antiox10091440] [Reference Citation Analysis]
113 Chavda VP, Apostolopoulos V. Omicron Variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly? Maturitas 2022. [DOI: 10.1016/j.maturitas.2022.01.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
114 Rahimmanesh I, Shariati L, Dana N, Esmaeili Y, Vaseghi G, Haghjooy Javanmard S. Cancer Occurrence as the Upcoming Complications of COVID-19. Front Mol Biosci 2022;8:813175. [DOI: 10.3389/fmolb.2021.813175] [Reference Citation Analysis]